GlassScriptPhysician profile
Michelle C Savarese
NPI 1487700316
$2,026.36
in general payments reported to CMS, 2019-2025
21 companies · $1,303 in 2025
The $1,303 reported for 2025 was more than what 92% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $13.76 · 2023: $135 · 2024: $575 · 2025: $1,303.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,013.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,012.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $532.26 | 2023-2025 | Gemtesa, Orgovyx |
| Tolmar, INC. | $282.64 | 2023-2025 | Jatenzo |
| Progenics Pharmaceuticals, INC. | $179.07 | 2023-2025 | Pylarify |
| Bayer Healthcare Pharmaceuticals INC. | $163.49 | 2024-2025 | |
| Antares Pharma, INC. | $129.71 | 2024-2025 | Xyosted |
| Janssen Biotech, INC. | $110.40 | 2023-2024 | Erleada |
| Merck Sharp & Dohme LLC | $102.87 | 2025 | Keytruda |
| Astellas Pharma US INC | $72.30 | 2025 | Xtandi |
| Medtronic, INC. | $66.65 | 2024 | Interstim |
| Endo USA, INC. | $49.46 | 2025 | Xiaflex, Aveed |
| C. R. Bard, INC. & Subsidiaries | $46.56 | 2025 | Magic3 Go Intermittent Urinary Catheter |
| Vertex Pharmaceuticals Incorporated | $45.80 | 2024-2025 | |
| Boston Scientific Corporation | $41.86 | 2025 | Axonics |
| Becton, Dickinson and Company | $36.75 | 2025 | Aptra |
| Dendreon Pharmaceuticals LLC | $29.75 | 2025 | Provenge |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $29.13 | 2025 | |
| Immunitybio, INC. | $28.94 | 2024 | |
| Pfizer INC. | $22.87 | 2025 | |
| Tempus Ai, INC | $22.22 | 2024 | Xt Cdx |
| Calyxo, INC. | $19.87 | 2025 | Cvac Aspiration System |
| Orthofix Medical, INC. | $13.76 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Savarese listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.